Einstein-Mount Sinai Diabetes Research Center

News & Announcements

Recent Publications

In vivo screen identifies a SIK inhibitor that induces β cell proliferation through a transient UPR.
Charbord J, Ren L, Sharma RB, Johansson A, Ågren R, Chu L, Tworus D, Schulz N, Charbord P, Stewart AF, Wang P, Alonso LC, Andersson O. Nat Metab. 2021 May;3(5):682-700. doi: 10.1038/s42255-021-00391-x. Epub 2021 May 20.PMID: 34031592

Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes.
McKimpson WM, Chen Y, Irving JA, Zheng M, Weinberger J, Tan WLW, Tiang Z, Jagger AM, Chua SC Jr, Pessin JE, Foo RS, Lomas DA, Kitsis RN. Dev Cell. 2021 Mar 22;56(6):747-760.e6. doi: 10.1016/j.devcel.2021.02.011. Epub 2021 Mar 4.PMID: 33667344.


New Fleischer Institute for Diabetes and Metabolism

Fleischer Institute for Diabetes

The newly established Fleischer Institute for Diabetes and Metabolism (Fleischer Institute) at Montefiore Einstein will serve as a major hub for discovery by conducting cutting edge basic, clinical, and translational research, and offering unique and innovative programs for the care of diabetes and metabolic disorders. Named after Dr. Norman Fleischer in honor of his pioneering research and seminal contributions to the field of diabetes and metabolic disorders, the Institute will continue his work of uncovering the molecular mechanisms underlying type 1 and type 2 diabetes and translating them into novel therapies.

The Institute is located on the Einstein Campus at 1180 Morris Park Avenue and led by Jill Crandall, MD, Chief, Endocrinology, and Director, Fleisher Institute.

"The idea is to create an overarching institute that will encompass existing efforts at Montefiore in the field of diabetes, and bring our many specialists together in one location," says Dr. Crandall.

Beginning in the 1970s, Dr. Fleischer built a robust Endocrine division at Einstein, having trained nearly 85 fellows; the division currently has 30 full-time faculty, as well as many trainees. Dr. Fleischer was a consummate physician improving the lives of countless patients with a special focus in recent years on the rising epidemic of diabetes and obesity in the Bronx. Dr. Fleischer’s lifelong commitment to social justice and the Bronx population made an enormous impact on our community which has one of the highest rates of diabetes in the country, with one in three adults living with the disease.

The Fleischer Institute for Diabetes and Metabolism will host leaders, scientists, physicians, nurses, and staff working together to respond to the diabetes and obesity epidemic through research, clinical programs, education, community outreach, and population health approaches. The Institute’s state-of-the-art facility at 1180 Morris Park Avenue, on the campus of the Albert Einstein College of Medicine, will be the most comprehensive center to care for and support patients with diabetes in the Bronx community as well as Northern Manhattan, Westchester County, and the Hudson Valley.

Montefiore Einstein is seeking partners to invest in our Institute in order to find new therapies for diabetes and obesity and to improve the health outcomes of local, national, and global populations. By supporting the Fleischer Institute for Diabetes and Metabolism with philanthropy, you help address one of the most significant epidemics of the 21ST century, and continue Dr. Norman Fleischer's legacy of making a world of difference to a world in need. To learn more or to make a donation click here

Designed to be the most comprehensive diabetes center in our service area, the new Fleischer Institute for Diabetes and Metabolism is now open. The Institute is located on the Einstein Campus at 1180 Morris Park Avenue and led by Jill Crandall, MD, Chief, Endocrinology, and Director, Fleisher Institute. The mission of the Fleischer Institute is to be a hub for discovery, where cutting-edge basic, clinical and translational research results in novel therapies as well as innovative programs to serve patients with diabetes and metabolic disorders.The Institute honors the memory of Dr. Norman Fleischer, a pioneering and innovative endocrinology researcher who built the robust research and clinical programs at Montefiore.

Norman Fleischer NYC Regional Diabetes Symposium & Rifkin Lectureship
May 3, 2019
Price Center, Lefrak Auditorium
Albert Einstein College of Medicine, Bronx, NY
Keynote Speaker: Martin Myers Jr., MD, PhD
Professor of Diabetes Research, Internal Medicine and Molecular Integrative Physiology, University of Michigan 

Click here to log in